- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Therapeutic Removal of Neutrophil Extracellular Traps from Blood in a Pig Model of Sepsis Video
- Share
- Tweet
- Share on Facebook
- Share
Presentation titled: Therapeutic Removal of Neutrophil Extracellular Traps from Blood in a Pig Model of Sepsis
Presented at: E-ISFA 2021 by Dr Andrew Aswani, Consultant in Intensive Care Medicine & Anesthesia at a leading London Hospital and Chief Medical Officer of Santersus AG and includes data showing that Nu.Q® is an effective method for monitoring a plasmapheresis treatment targeting NETs in sepsis.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields